Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-014473

President and CEO acquired 65,047 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schultz Kare · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-28 Exercise or conversion : show line 1 in the form +65,047 1,132,496 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-28 Exercise or conversion : show line 2 in the form Restricted Share Units −65,047 130,096 D
Loading xslF345X03/doc4.xml…